-The Times of India JORHAT: The surge in the water level of the Brahmaputra and its tributaries aggravated the flood situation in Dhemaji, Jorhat and Golaghat districts on Sunday. Dhemaji district Administration opened five relief camps in the district and has even started distribution of relief material among flood victims. According to a Central Water Commission report, the water level of the Brahmaputra at Neematighat in Jorhat district was 87.73cm on Sunday...

-The Hindu "Why this selective concern about encounter killings in Gujarat - these happen all over the country," pleaded Gujarat's lawyer at a Supreme Court hearing of veteran journalist B.G. Verghese's public interest petition on 22 unexplained police killings in that state. When a 13-year-old boy was abducted from a Delhi jhuggi by Gujarat police officials on a whim, the State government's defence was first that the boy was Bangladeshi, next that...

-The Telegraph New Delhi: The housing ministry is thinking of setting up an institute of urban planning that will act as a think tank as well as train personnel in city planning. The Prime Minister will chair the governing body of the institute, which will be located in Delhi. The Delhi Development Authority has sanctioned five acres for the institute, to be built with a budget of Rs 300 crore. The government plans...

-The Hindu Deputy Commissioner asks officials to redouble efforts against illegal activities Gulbarga: Deputy Commissioner N.S. Prasanna Kumar on Wednesday reaffirmed that there would not be any let-up in the crackdown against illegal extraction and hoarding of sand and the district officials have been asked to redouble their efforts to put down such illegal activities. Talking to presspersons here, Mr. Prasanna Kumar said that 350 truckloads of sand illegally hoarded in open spaces...

-The Economic Times NEW DELHI: After the UK drug regulator, the Australian drug regulator has also said that the drugs marketed by Ranbaxy Labs are safe. "At present, there is no evidence that any of the products in the Australian market manufactured by Ranbaxy are of an unacceptable quality or that there is a danger to consumers in Australia," a spokesperson for the Australian Therapeutic Goods Administration (TGA) told ET. The Australian...